64P Molecularly unselected immune-based versus non-immune-based trials: Outcomes in refractory metastatic castrate resistant prostate cancer (mCPRC) at Sarah Cannon Research Institute (SCRI) UK

Read full text Summarise with VIRAT
Authors: Khobe Chandran, Hamad Almarzouq, Y.F. Zheng, B. Kelly, L. Kenehan, A. Williams, Rafael Maciel Grochot, Rueben Amofa, E. Fontana
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Fields of Study & Subjects

Prostate Cancer Treatment and Research Cancer Immunotherapy and Biomarkers Prostate Cancer Diagnosis and Treatment

Publication details

Journal / source
ESMO Open
Volume
11
Pages
106205–106205
Publication date
1 April 2026
Language
EN